Nuzenio

Circular Rna Car

Circular Rna Car news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 4 publisher sources 100/100 entity strength

Latest news

RiboX’s Circular RNA CAR-T IND Clearance Forces the Industry to Rethink Everything It Knows About Cell Therapy Trial Design - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sun, 09 Aug 2026 07:28:07 GMTFDA Clears IND for RiboX’s RXIM002, Circular RNA CAR-T for ITP - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sun, 09 Aug 2026 06:34:09 GMTRiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias - The Manila TimesThe Manila Times · Sat, 08 Aug 2026 08:04:32 GMTIn Vivo CAR-T's Liver Problem Now Has Targeted Answer: CREATE Acquires Monash's 8-Fold LNP Fix - Tech TimesTech Times · Fri, 31 Jul 2026 17:14:57 GMTJ&J pays Sail $785M, charting course to possible in vivo CAR-T buyout - Fierce BiotechFierce Biotech · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Sun, 09 Aug 2026 07:28:07 GMTRiboX’s Circular RNA CAR-T IND Clearance Forces the Industry to Rethink Everything It Knows About Cell Therapy Trial Design - The Clinical Trial Vanguard
Sun, 09 Aug 2026 06:34:09 GMTFDA Clears IND for RiboX’s RXIM002, Circular RNA CAR-T for ITP - The Clinical Trial Vanguard
Sat, 08 Aug 2026 08:04:32 GMTRiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias - The Manila Times
Fri, 31 Jul 2026 17:14:57 GMTIn Vivo CAR-T's Liver Problem Now Has Targeted Answer: CREATE Acquires Monash's 8-Fold LNP Fix - Tech Times
Thu, 30 Jul 2026 07:00:00 GMTJ&J pays Sail $785M, charting course to possible in vivo CAR-T buyout - Fierce Biotech

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Circular Rna Car.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.